TFCP2L1 and cancer: Conversely, pluripotency transcription factors, including NANOG, POU5F1 (encoding OCT4), and TFCP2L1 (encoding LBP9), that control HERVH activity in human ES cells (27) associated with HERVH-CALB1 expression in other cancer types, but not in LUSC (Supplemental Figure 8).